Drug intelligence / Profile preview

Biyan Tong Granule

Development stage: Preclinical
Lead developer: Kangcheng Pharmaceutical
Administration: Oral

Overview

Biyan Tong Granule is a Traditional Chinese Medicine (TCM) formulation currently under development by Kangcheng Pharmaceutical, a subsidiary of the Guangxi Liuyao Group. It is developed as an oral granule specifically for the treatment of rhinitis. As a herbal medicine, it is composed of multiple botanical extracts intended to alleviate symptoms such as nasal congestion and inflammation. The product is currently in the pilot study and development phase, with the developer conducting research to establish its efficacy and safety profile for clinical use.

Brand names: Biyan Tong
Other names: Biyan Tong Keli鼻炎通颗粒

Beyond the preview

Go deeper on Biyan Tong Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biyan Tong Granule.

Explore the full profile